
DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
PowerHouse Energy Group plc (LON:PHE) has today announced that it has advised AFC Energy plc (LON:AFC) that it wishes to take delivery of a small scale fuel cell system it..
Versarien plc (LON:VRS), the advanced materials group, has this afternoon announced a fundraising of approximately £1 million (before expenses) by the issue and allotment by the Company of approximately 6.7..
Blue Star Capital Plc (LON:BLU) CEO Anthony Fabrizi talks to DirectorsTalk about the increase in its holding in Blockchain Nanopayments company SatoshiPay Ltd. Tony explains why he likes the company,..
Vertu Motors Plc (LON:VTU) are the topic of conversation when Zeus Capital head of research Mike Allen caught up with DirectorsTalk. Mike talks us through the key drivers that kept..
Powerhouse Energy Group Plc (LON:PHE) Executive Chairman Keith Allaun talks to DirectorsTalk about the siting of the G3-UHT Demonstration Unit at the Thornton Science Park, near the University of Chester...
Veltyco Group Plc (LON:VLTY) is the topic of conversation when Director of Equity Research for Northland Capital Partners Mike Campbell talks with DirectorsTalk. Mike talks us through the Valentines day..
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its new monitor sales in the US and UK. Ewan explains how the orders came about, the focus..
ITM Power Plc (LON:ITM) is the topic of discussion when Zeus Capital Research Director Tom McColm caught up with DirectorsTalk to talk about the first hydrogen station to be situated..
MTI Wireless Edge Limited (LON:MWE) Chief Financial Officer Moni Borovitz talks to DirectorsTalk about its latest contract win worth 1.8million US dollars, in the wireless access BWA sector. Moni explains..
Gresham House Plc (LON:GHE) yesterday announced the launch of a new “longer term capital” investment platform and that The Royal County of Berkshire Pension Fund intends to become a strategic..
Proactis Holdings Plc (LON:PHD) CFO Tim Sykes talks to DirectorsTalk about its latest trading update for the six months ended 31 January 2017. Tim explains the key drivers behind a..
Blue Star Capital Plc (LON:BLU) recently invested in digital payment company SatoshiPay. The successful funding was lead by early supporter Jim Mellon. With blockchain technology having the potential to revolutionise..
Surface Transforms Plc (LON:SCE) Chairman David Bundred catches up with DirectorsTalk to discuss announcements made since we last spoke. David talks about the importance of the deal with Aston Martin,..
Lighthouse Group Plc (LON:LGT) CEO Malcolm Streatfield talks to DirectorsTalk about the strong set of results for 2016 issued. Malcolm talks us through the highlights, explains the sunset clause arrangements..
City of London Investment Group Plc (LON:CLIG) is the topic of discussion when Robin Savage, Research Director at Zeus Capital caught up with DirectorsTalk. Robin compares the interim results for..
Goldplat Plc (LON:GDP) are the topic of discussion when Oliver O’Donnell, mining analyst at VSA Capital caught up with DirectorsTalk to discuss company interims. Oliver discusses 2016 issues, how currency..
Versarien Plc (LON:VRS) the advanced materials group, CEO Neill Ricketts talks to DirectorsTalk about its agreement with Lansdowne Chemicals. Neill explains the background to the deal, its significance, how they..
“Expand our horizons dramatically”, “Boots on the ground”, “Very confident in the future” are just some of the phrases Keith Allaun, Executive Chairman for PowerHouse Energy Group Plc (LON:PHE) uses..
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval..



















